42Stockpicking

UTMD

Utah Medical Products IncKøb· 77.1%· 4. jun. 2026
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
10,7
22nd %ile · 158p
EV/EBITDAi
6,8
42nd %ile · 83p
P/Bi
1,8
26th %ile · 404p
P/Si
3,2
46th %ile · 356p
EV/Salesi
1,9
36th %ile · 356p
Div yieldi

Kursudvikling

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026full
Prishistorik
27,2 år
Pris-dage
6856
Årsregnskaber
18
Peers
0/0
Valuation
5/6
Fundamentals
8/8
Datovindue
1999-03-08 til 2026-06-08

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

UTMD vurderet 2026-06-10

Score
85.4%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

97%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

100%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

92%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

94%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

80%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

73%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: Own P/E 10.7 vs peer median 12.6; cheaper than peers if business quality is comparable.

Insider activity

DatoPersonRolleTypeAntalVærdiKilde
29.6.2026RICHINS PAUL O◇ GAVE-150-10.961 USDsec
28.5.2026Koopman BrianPrincipal Financial Officer◇ GAVE-50-3.314 USDsec

Earnings

Ingen earnings-historik for denne ticker endnu.
Ingen earnings-data endnu.